Types of virus | Caused disease | Example of treatment method | Example of diagnostic method | Refs. |
---|---|---|---|---|
Variola virus | Smallpox | Vaccines and antiviral agents/drugs (e.g. tecovirimat, cidofovir and brincidofovir) | Immune serum complement fixation test; physical exam of skin | |
HIV | Acquired immunodeficiency syndrome (AIDS) | Antiretroviral agents/drugs (e.g. NRTIs and NNRTIs) HIV protease inhibitors (e.g. mozenavir) HIV vaccines (e.g. neutralizing antibodies and recombinant viral vectors) | PCR or viral load test; P24 test; ELISA; rapid finger prick and oral swab test; Western blot test | [4] |
SARS | Severe acute respiratory syndrome (SARS) | Antiviral agents/drugs (e.g. ribavirin, corticosteroid, and type 1 IFN); convalescent plasma and immunoglobulin | Serology; real time reverse transcription PCR; ELISA | [5] |
MERS | Middle east respiratory syndrome (MERS) | Antiviral agents/drugs (e.g. type 1 IFN, IFN-α2b combined with ribavirin, chloroquine, and lopinavir); convalescent sera from recovered patients | Serology; real time reverse transcription PCR; ELISA; Immunofluorescence assay | [6] |
Ebola | Ebola hemorrhagic fever | Monoclonal antibodies (e.g. REGN-EB3, mAb114, and ZMapp); antiviral agents/drugs (e.g. remdesivir) | Quantitative reverse transcription PCR; ELISA antigen capture; Ebola-specific IgM and IgG antibody detection | [7] |
SARS-CoV-2 | Coronavirus disease 2019 (COVID-19) | Vaccines (e.g. inactivated vaccines, mRNA vaccines, recombinant protein vaccines, and live attenuated vaccines); antiviral agents/drugs (e.g. umifenovir; lopinavir, ritonavir, tocilizumab, and sarilumab) | Real time reverse transcription PCR by using nasal swab or sputum sample; blood and antibody test |